740 Views | 820 Downloads
Correspondence: A. M. Harris, MD, MPH, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS G-37, Atlanta, GA 30329 amharris@cdc.gov
See publication for full list of author contributions.
We thank the children and families who graciously consented to participate in the Etiology of Pneumonia in the Community (EPIC) study.
We also thank Dr. Chris Stockmann (University of Utah Health Services Center) for his contributions to this study.
Potential conflicts of interest: W. H. S. serves on scientific advisory boards for BioFire Diagnostics and Venaxis, Inc., consults for Abbott Point of Care, and received research funding from Pfizer, ThermoFisher, and BioMerieux.
E. J. A. received research funding from Novavax and research funding and editorial assistance from MedImmune, and he consults for AbbVie. R. G. W. consults with Accelerate Diagnostics and GenMark, and his institution received grants from bioMerieux and Pfizer.
A. T. P. received research funding from BioFire Diagnostics. C. G. G. has served as a consultant for Pfizer Inc.
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
The EPIC study was supported by the Influenza Division in the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention through cooperative agreements with each study site and was based on a competitive research funding opportunity.
W. H. S. was supported in part by K23GM110469 from the National Institute of General Medical Sciences.
C. G. G. was supported in part by R01AG043471 from the National Institute on Aging.
D. J. W. was supported in part by K23AI104779 from the National Institute of Allergy and Infectious Diseases.
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.